Clinical Exercise Physiology – Exercise Management for Chronic Diseases and Special Populations
Autor Jonathan K Ehrman, Paul Gordon, Paul Visich, Steven J. Keteyianen Limba Engleză Paperback – 20 apr 2022
Preț: 691.72 lei
Preț vechi: 898.34 lei
-23% Nou
Puncte Express: 1038
Preț estimativ în valută:
132.38€ • 137.51$ • 109.96£
132.38€ • 137.51$ • 109.96£
Carte disponibilă
Livrare economică 13-27 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 73.08 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781718200449
ISBN-10: 1718200447
Pagini: 656
Dimensiuni: 214 x 283 x 30 mm
Greutate: 1.75 kg
Ediția:Fifth Edition
Editura: MG – Human Kinetics
ISBN-10: 1718200447
Pagini: 656
Dimensiuni: 214 x 283 x 30 mm
Greutate: 1.75 kg
Ediția:Fifth Edition
Editura: MG – Human Kinetics
Notă biografică
Jonathan K. Ehrman, PhD, is the associate program director of preventive cardiology at Henry Ford Hospital in Detroit, where he also serves as chair of the institutional review board. He has a 36-year background in clinical exercise physiology and is certified by the American College of Sports Medicine (ACSM) as a clinical exercise physiologist and as a program director. He previously served as the chair of the clinical exercise physiologist credentialing committee for ACSM.
Dr. Ehrman is the author of more than 200 manuscripts and abstracts as well as several textbooks and chapters. He currently serves as editor in chief of the Journal of Clinical Exercise Physiology and was an associate editor of the 10th edition of ACSM’s Guidelines for Exercise Testing and Prescription. He is also the coeditor of the sixth edition of the American Association of Cardiovascular and Pulmonary Rehabilitation’s Guidelines for Cardiac Rehabilitation Programs. He is a fellow of ACSM and the American Association of Cardiovascular and Pulmonary Rehabilitation and is a member of the American Heart Association and the American College of Cardiology. Dr. Ehrman earned his PhD in clinical exercise physiology from The Ohio State University.
Paul M. Gordon, PhD, MPH, is a professor and head of the department of health, human performance, and recreation at Baylor University. He is certified by the American College of Sports Medicine (ACSM) as a clinical exercise physiologist and has over 20 years of experience teaching clinical exercise physiology curricula and directing cardiopulmonary rehabilitation programs. Gordon’s areas of expertise include physical activity and lifestyle-based research related to obesity and its comorbidities across the life span. He has published more than 200 papers and abstracts as well as several chapters, including contributions to ACSM’s Guidelines for Exercise Testing and Prescription. He has also served as an examiner and coordinator for ACSM certification and credentialing.
Dr. Gordon is a fellow of ACSM, the Obesity Society, and the Centers for Disease Control Physical Activity Research Program. He is an international member of the Royal Society of Medicine. He earned his PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh.
Paul S. Visich, PhD, MPH, is a professor and chair of the exercise and sports performance department at the University of New England. He has over 20 years of experience in clinical exercise physiology and previously served as director of the Human Performance Laboratory in the College of Health Professions at Central Michigan University. He worked for 12 years in a clinical setting that included cardiac and pulmonary rehabilitation and primary disease prevention. His research interests involve the assessment of cardiovascular disease risk factors in children, the influence of resistance training in elderly populations, and altitude physiology.
Dr. Visich previously served as a member of the American College of Sport Medicine (ACSM) exercise physiology credentialing committee and as chair of their professional education committee. He is the author of more than 70 published scientific articles and abstracts. He earned a PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh.
Steven J. Keteyian, PhD, has more than 40 years of experience working as a clinical exercise physiologist. He is program director of preventive cardiology at the Henry Ford Hospital in Detroit. He is also an adjunct professor in the department of physiology at Wayne State University in Detroit. Over the course of his career, Dr. Keteyian has focused on exercise and physical activity in both healthy individuals and those with chronic diseases. He is the author of more than 250 scientific articles and book chapters, as well as four textbooks, and he previously served as editor in chief for ACSM's Health & Fitness Journal.
Dr. Keteyian is a member of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. He earned his PhD from Wayne State University in Detroit.
Dr. Ehrman is the author of more than 200 manuscripts and abstracts as well as several textbooks and chapters. He currently serves as editor in chief of the Journal of Clinical Exercise Physiology and was an associate editor of the 10th edition of ACSM’s Guidelines for Exercise Testing and Prescription. He is also the coeditor of the sixth edition of the American Association of Cardiovascular and Pulmonary Rehabilitation’s Guidelines for Cardiac Rehabilitation Programs. He is a fellow of ACSM and the American Association of Cardiovascular and Pulmonary Rehabilitation and is a member of the American Heart Association and the American College of Cardiology. Dr. Ehrman earned his PhD in clinical exercise physiology from The Ohio State University.
Paul M. Gordon, PhD, MPH, is a professor and head of the department of health, human performance, and recreation at Baylor University. He is certified by the American College of Sports Medicine (ACSM) as a clinical exercise physiologist and has over 20 years of experience teaching clinical exercise physiology curricula and directing cardiopulmonary rehabilitation programs. Gordon’s areas of expertise include physical activity and lifestyle-based research related to obesity and its comorbidities across the life span. He has published more than 200 papers and abstracts as well as several chapters, including contributions to ACSM’s Guidelines for Exercise Testing and Prescription. He has also served as an examiner and coordinator for ACSM certification and credentialing.
Dr. Gordon is a fellow of ACSM, the Obesity Society, and the Centers for Disease Control Physical Activity Research Program. He is an international member of the Royal Society of Medicine. He earned his PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh.
Paul S. Visich, PhD, MPH, is a professor and chair of the exercise and sports performance department at the University of New England. He has over 20 years of experience in clinical exercise physiology and previously served as director of the Human Performance Laboratory in the College of Health Professions at Central Michigan University. He worked for 12 years in a clinical setting that included cardiac and pulmonary rehabilitation and primary disease prevention. His research interests involve the assessment of cardiovascular disease risk factors in children, the influence of resistance training in elderly populations, and altitude physiology.
Dr. Visich previously served as a member of the American College of Sport Medicine (ACSM) exercise physiology credentialing committee and as chair of their professional education committee. He is the author of more than 70 published scientific articles and abstracts. He earned a PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh.
Steven J. Keteyian, PhD, has more than 40 years of experience working as a clinical exercise physiologist. He is program director of preventive cardiology at the Henry Ford Hospital in Detroit. He is also an adjunct professor in the department of physiology at Wayne State University in Detroit. Over the course of his career, Dr. Keteyian has focused on exercise and physical activity in both healthy individuals and those with chronic diseases. He is the author of more than 250 scientific articles and book chapters, as well as four textbooks, and he previously served as editor in chief for ACSM's Health & Fitness Journal.
Dr. Keteyian is a member of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. He earned his PhD from Wayne State University in Detroit.
Cuprins
Part I. Introduction to Clinical Exercise Physiology
Chapter 1. The Profession of Clinical Exercise Physiology
Jonathan K. Ehrman, PhD, Paul M. Gordon, PhD, MPH, Paul S. Visich, PhD, MPH, and Steven J. Keteyian, PhD
The Past, Present, and Future of Clinical Exercise Physiology
Professional Organizations and Certifications Throughout the World
Professionalization of Clinical Exercise Physiology
Conclusion
Chapter 2. Promoting a Physically Active Lifestyle
Anna G. Beaudry, BS, Danielle A. Young, PsyD, and Annie T. Ginty, PhD
Benefits of Physical Activity
Participation in Regular Physical Activity
Conclusion
Chapter 3. General Principles of Pharmacology
Steven J. Keteyian, PhD
General Properties of Drugs
Routes of Administration
Phases of Drug Effect
Mechanism of Action
Pharmacotherapy
Conclusion
Chapter 4. General Interview and Examination Skills
Lizbeth R. Brice, MD
General Interview
Physical Examination
Conclusion
Chapter 5. Graded Exercise Testing
Steven J. Keteyian, PhD
Indications
Contraindications
Procedures for Preparing, Conducting, and Interpreting a Graded Exercise Test
Graded Exercise Testing With Diagnostic Imaging
Conclusion
Chapter 6. Exercise Prescription
Steven J. Keteyian, PhD
Exercise Training Sequence
Goal Setting
Principles of Exercise Prescription
Cardiorespiratory Endurance
Skeletal Muscle Strength and Endurance
Flexibility Training
Conclusion
Chapter 7. Clinical Exercise Programming
Jonathan K. Ehrman, PhD
Cardiac Rehabilitation
Pulmonary Rehabilitation
Supervised Exercise Therapy for Patients With Peripheral Artery Disease
Cancer Rehabilitation
Renal Rehabilitation
General Exercise Programs for Patients With Chronic Disease
Conclusion
Part II. Diseases of the Endocrine System and Metabolic Disorders
Chapter 8. Diabetes
Sheri R. Colberg, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 9. Obesity
David C. Murdy, MD, Dennis J. Kerrigan, PhD, and Jonathan K. Ehrman, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 10. Hypertension
Yin Wu, PhD, and Linda S. Pescatello, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 11. Hyperlipidemia and Dyslipidemia
Paul G. Davis, PhD, Peter W. Grandjean, PhD, Stephen F. Crouse, PhD, and J. Larry Durstine, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 12. Metabolic Syndrome
James R. Churilla, PhD, MPH, MS
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 13. Chronic Kidney Disease
Samuel Headley, PhD, Kenneth Wilund, PhD, and Michael Germain, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part III. Diseases of the Cardiovascular System
Chapter 14. Acute Coronary Syndromes
Ray W. Squires, PhD
Pathophysiology
Clinical Assessment
Exercise Training: Inpatient Cardiac Rehabilitation
Exercise Training: Early Outpatient Cardiac Rehabilitation
Exercise Prescription
Conclusion
Chapter 15. Revascularization of the Heart
Neil A. Smart, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Chapter 16. Chronic Heart Failure
Steven J. Keteyian, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 17. Peripheral Artery Disease
Ryan J. Mays, PhD, MPH, Ivan P. Casserly, MB, BCh, and Judith G. Regensteiner, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 18. Cardiac Electrical Pathophysiology
Kerry J. Stewart, EdD, and David D. Spragg, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Part IV. Diseases of the Respiratory System
Chapter 19. Chronic Obstructive Pulmonary Disease
Satvir S. Dhillon, MSc, Dennis Jensen, PhD, and Jordan A. Guenette, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 20. Asthma
Louis-Philippe Boulet, MD, Simon Bacon, PhD, and Andréanne Côté, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 21. Cystic Fibrosis
Kelley Crawford, DPT, CCS
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part V. Diseases of the Immune System and Oncology
Chapter 22. Cancer
Dennis J. Kerrigan, PhD, and Karen Wonders, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 23. Human Immunodeficiency Virus
Vitor H.F. Oliveira, PhD, MS, Christine Horvat Davey, PhD, RN, and Allison R. Webel, PhD, RN
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part VI. Disorders of the Bones and Joints
Chapter 24. Arthritis
Melissa Nayak, MD, and Andrew K. Cunningham, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 25. Osteoporosis
Lora M. Giangregorio, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 26. Nonspecific Low Back Pain
Peter Ronai, MS
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Part VII. Disorders of the Neuromuscular System
Chapter 27. Spinal Cord Injury
Sean M. Tweedy, PhD, Emma M. Beckman, PhD, Mark J. Connick, PhD, Anne L. Hart, PhD, Kati Karinharju, PhD, Kelly M. Clanchy, PhD, and Timothy Geraghty, FAFRM (RACP)
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 28. Multiple Sclerosis
Ulrik Dalgas, PhD, and Lars G. Hvid, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 29. Cerebral Palsy
Désirée B. Maltais, PT, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 30. Stroke
Christopher J. Womack, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Conclusion
Chapter 31. Parkinson’s Disease
Angela L. Ridgel, PhD, and Brandon S. Pollock, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part VIII. Special Populations
Chapter 32. Children
Timothy J. Michael, PhD, and Carol Weideman, PhD
Definition
Scope
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 33. Older Adults
Jerome L. Fleg, MD, and Daniel E. Forman, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Chapter 34. Depression
Grace M. McKeon, PhD Candidate, and Simon Rosenbaum, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Chapter 35. Intellectual Disability
Tracy Baynard, PhD, and Bo Fernhall, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 1. The Profession of Clinical Exercise Physiology
Jonathan K. Ehrman, PhD, Paul M. Gordon, PhD, MPH, Paul S. Visich, PhD, MPH, and Steven J. Keteyian, PhD
The Past, Present, and Future of Clinical Exercise Physiology
Professional Organizations and Certifications Throughout the World
Professionalization of Clinical Exercise Physiology
Conclusion
Chapter 2. Promoting a Physically Active Lifestyle
Anna G. Beaudry, BS, Danielle A. Young, PsyD, and Annie T. Ginty, PhD
Benefits of Physical Activity
Participation in Regular Physical Activity
Conclusion
Chapter 3. General Principles of Pharmacology
Steven J. Keteyian, PhD
General Properties of Drugs
Routes of Administration
Phases of Drug Effect
Mechanism of Action
Pharmacotherapy
Conclusion
Chapter 4. General Interview and Examination Skills
Lizbeth R. Brice, MD
General Interview
Physical Examination
Conclusion
Chapter 5. Graded Exercise Testing
Steven J. Keteyian, PhD
Indications
Contraindications
Procedures for Preparing, Conducting, and Interpreting a Graded Exercise Test
Graded Exercise Testing With Diagnostic Imaging
Conclusion
Chapter 6. Exercise Prescription
Steven J. Keteyian, PhD
Exercise Training Sequence
Goal Setting
Principles of Exercise Prescription
Cardiorespiratory Endurance
Skeletal Muscle Strength and Endurance
Flexibility Training
Conclusion
Chapter 7. Clinical Exercise Programming
Jonathan K. Ehrman, PhD
Cardiac Rehabilitation
Pulmonary Rehabilitation
Supervised Exercise Therapy for Patients With Peripheral Artery Disease
Cancer Rehabilitation
Renal Rehabilitation
General Exercise Programs for Patients With Chronic Disease
Conclusion
Part II. Diseases of the Endocrine System and Metabolic Disorders
Chapter 8. Diabetes
Sheri R. Colberg, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 9. Obesity
David C. Murdy, MD, Dennis J. Kerrigan, PhD, and Jonathan K. Ehrman, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 10. Hypertension
Yin Wu, PhD, and Linda S. Pescatello, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 11. Hyperlipidemia and Dyslipidemia
Paul G. Davis, PhD, Peter W. Grandjean, PhD, Stephen F. Crouse, PhD, and J. Larry Durstine, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 12. Metabolic Syndrome
James R. Churilla, PhD, MPH, MS
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 13. Chronic Kidney Disease
Samuel Headley, PhD, Kenneth Wilund, PhD, and Michael Germain, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part III. Diseases of the Cardiovascular System
Chapter 14. Acute Coronary Syndromes
Ray W. Squires, PhD
Pathophysiology
Clinical Assessment
Exercise Training: Inpatient Cardiac Rehabilitation
Exercise Training: Early Outpatient Cardiac Rehabilitation
Exercise Prescription
Conclusion
Chapter 15. Revascularization of the Heart
Neil A. Smart, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Chapter 16. Chronic Heart Failure
Steven J. Keteyian, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 17. Peripheral Artery Disease
Ryan J. Mays, PhD, MPH, Ivan P. Casserly, MB, BCh, and Judith G. Regensteiner, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 18. Cardiac Electrical Pathophysiology
Kerry J. Stewart, EdD, and David D. Spragg, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Part IV. Diseases of the Respiratory System
Chapter 19. Chronic Obstructive Pulmonary Disease
Satvir S. Dhillon, MSc, Dennis Jensen, PhD, and Jordan A. Guenette, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 20. Asthma
Louis-Philippe Boulet, MD, Simon Bacon, PhD, and Andréanne Côté, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 21. Cystic Fibrosis
Kelley Crawford, DPT, CCS
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part V. Diseases of the Immune System and Oncology
Chapter 22. Cancer
Dennis J. Kerrigan, PhD, and Karen Wonders, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 23. Human Immunodeficiency Virus
Vitor H.F. Oliveira, PhD, MS, Christine Horvat Davey, PhD, RN, and Allison R. Webel, PhD, RN
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part VI. Disorders of the Bones and Joints
Chapter 24. Arthritis
Melissa Nayak, MD, and Andrew K. Cunningham, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 25. Osteoporosis
Lora M. Giangregorio, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 26. Nonspecific Low Back Pain
Peter Ronai, MS
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Part VII. Disorders of the Neuromuscular System
Chapter 27. Spinal Cord Injury
Sean M. Tweedy, PhD, Emma M. Beckman, PhD, Mark J. Connick, PhD, Anne L. Hart, PhD, Kati Karinharju, PhD, Kelly M. Clanchy, PhD, and Timothy Geraghty, FAFRM (RACP)
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 28. Multiple Sclerosis
Ulrik Dalgas, PhD, and Lars G. Hvid, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 29. Cerebral Palsy
Désirée B. Maltais, PT, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 30. Stroke
Christopher J. Womack, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Conclusion
Chapter 31. Parkinson’s Disease
Angela L. Ridgel, PhD, and Brandon S. Pollock, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Part VIII. Special Populations
Chapter 32. Children
Timothy J. Michael, PhD, and Carol Weideman, PhD
Definition
Scope
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion
Chapter 33. Older Adults
Jerome L. Fleg, MD, and Daniel E. Forman, MD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Chapter 34. Depression
Grace M. McKeon, PhD Candidate, and Simon Rosenbaum, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription and Training
Conclusion
Chapter 35. Intellectual Disability
Tracy Baynard, PhD, and Bo Fernhall, PhD
Definition
Scope
Pathophysiology
Clinical Considerations
Exercise Prescription
Exercise Training
Conclusion